BOSTON–(BUSINESS WIRE)–Humedica, the leading
clinical analytics company, today announced the launch of a new predictive
analytic model that will identify patients at high-risk for a Congestive Heart
Failure (CHF) hospitalization. Designed to enable providers to identify
high-risk CHF patients before they have been hospitalized, this tool can help
reduce hospital admissions among the sickest, most costly patients in America.
Developed with clinical data pulled directly from the electronic
medical record (EMR), the Humedica system is more accurate and more-timely than
other predictive analytic tools that are based upon claims-based risk
predictors.
“We are leveraging the power of millions of patient
experiences in our data warehouse, and are providing highly predictive
capabilities that identify CHF patients who would likely end up hospitalized
without prior medical intervention,” said Dr. Paul Bleicher, Humedicas Chief
Medical Officer. “Humedica is empowering clinicians to target specific groups
of high-risk CHF patients and intervene before their condition worsens.”
Mary Jane Hall, Chief Nursing Executive at the Community
Physician Network in Indiana
commented, “Adopting predictive analytics capabilities into our practices are a
critical part of our clinical arsenal and a key ingredient in our ability to
thrive in an Accountable Care reimbursement model. Clinically-powered tools
that help us target certain patients with appropriate interventions to avoid
sub-optimal outcomes before they occur enable us to take a bold step into the
future of health care.” The Community Physician Network in Indiana, which is joined by other Humedica
MinedShare® users in accessing the newly launched CHF predictive model, is in
the process of rolling-out the tool throughout its organization.
CHF is the most costly and most preventable cause of
inpatient admissions in the US,
costing an estimated $35 billion/year. Heart failure affects nearly 5 million
patients nationwide with 500,000 new cases diagnosed annually. Despite
well-known and highly effective interventions, 40% of all Medicare patients
with CHF are readmitted within 90 days.
“Predictive analytics powered by clinically-rich data is the
future of health care and we are very excited to be on the leading edge of this
innovation,” said Michael Weintraub, Humedicas President and CEO. “As health
care providers move squarely into risk-based population health management, they
need cutting edge systems that will help them improve patient care and lower
cost. As one of the most costly and most preventable outcomes, CHF
hospitalization is a great place to start.”
About Humedica
Humedica is a next-generation clinical analytics company that provides novel
software-as-a-service (SaaS)-based business intelligence solutions to the
health care industry. Through cutting- edge analytics, Humedica connects
patient information across varied medical settings and time periods to generate
a truly longitudinal and comprehensive view of patient care. Humedica provides our
partners and customers with the informatics solutions necessary to improve,
manage, and succeed in todays dynamic health care market. Humedica is defining
knowledge in health care. For more information, visit www.humedica.com.
Posted by Sean Fenske, Editor-in-Chief, MDT
